Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries
Author:
Affiliation:
1. Institute of Social and Preventive Medicine, Switzerland
2. Department of Rheumatology, Immunology and Allergology, University Hospital and University of Bern, Switzerland
Funder
Boehringer Ingelheim
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Link
http://academic.oup.com/rheumatology/article-pdf/57/2/354/23610067/kex394.pdf
Reference153 articles.
1. Causal diagrams for epidemiologic research;Greenland;Epidemiology,1999
2. Assessing the generalizability of randomized trial results to target populations;Stuart;Prev Sci Off J Soc Prev Res,2015
3. Observational cohort studies and well controlled clinical trials—we need them both!;Furst;J Rheumatol,2004
4. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?;Pincus;Ann Rheum Dis,2004
5. Generalizing evidence from randomized clinical trials to target populations the actg 320 trial;Cole;Am J Epidemiol,2010
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project;Pharmacological Research;2024-02
2. Crimson clues: advancing endometriosis detection and management with novel blood biomarkers;Fertility and Sterility;2024-02
3. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study;Cochrane Database of Systematic Reviews;2024-01-04
4. Connective tissue disease related interstitial lung disease: a single center experience;The European Research Journal;2023-11-04
5. Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study;Rheumatology and Therapy;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3